{"ORPHApacket":[{"ORPHApacketID":"158057","date":"2019-12-05 22:54:15","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"158057","Name":[{"lang":"en","label":"Acquired hemophagocytic lymphohistiocytosis associated with malignant disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_158057","DisorderType":[{"Name":[{"lang":"en","label":"Particular clinical situation in a disease or syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377793"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Secondary hemophagocytic lymphohistiocytosis"}],"ORPHA":"158041","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_158041"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A rare, secondary hemophagocytic lymphohistiocytosis characterized by occurring as either initial presentation of a malignant disease or at any stage during chemotherapy. The common associated malignancies are lukemias, B-cell, T-cell or NK-cell lymphomas, and Hodgkin lymphoma. Typical clinical manifestation includes fever, hepatosplenomegaly and cytopenias, combined with specific laboratory findings."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"All ages"}]}]}]}]}